Influence of structural and functional modifications of selected genotoxic carcinogens on metabolism and mutagenicity – a review

Alterations in molecular structure are responsible for the differential biological response(s) of a chemical inside a biosystem. Structural and functional parameters that govern a chemical's metabolic course and determine its ultimate outcome in terms of mutagenic/carcinogenic potential are extensively reviewed here. A large number of environmentally-significant organic chemicals are addressed under one or more broadly classified groups each representing one or more characteristic structural feature. Numerous examples are cited to illustrate the influence of key structural and functional parameters on the metabolism and DNA adduction properties of different chemicals. It is hoped that, in the event of limited experimental data on a chemical's bioactivity, such knowledge of the likely roles played by key molecular features should provide preliminary information regarding its bioactivation, detoxification and/or mutagenic potential and aid the process of screening and prioritising chemicals for further testing.

[1]  M. Colvin,et al.  Chemical and biological factors affecting mutagen potency. , 1998, Mutation research.

[2]  L. Peterson,et al.  The formation of substituted 1,N6-etheno-2'-deoxyadenosine and 1,N2-etheno-2'-deoxyguanosine adducts by cis-2-butene-1,4-dial, a reactive metabolite of furan. , 2004, Chemical research in toxicology.

[3]  K. Kaiser,et al.  QSAR in Environmental Toxicology , 1984, Springer Netherlands.

[4]  Ferenc Darvas,et al.  Metabolexpert: An Expert System for Predicting Metabolism of Substances , 1987 .

[5]  S. Safe,et al.  Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. , 1994, Critical reviews in toxicology.

[6]  A. Hakura,et al.  Dual stimulatory and inhibitory effects of fluorine-substitution on mutagenicity: an extension of the enamine epoxide theory for activation of the quinoline nucleus. , 1997, Biological & pharmaceutical bulletin.

[7]  J. Epler,et al.  Mutagenicity of cyclic nitrosamines in Salmonella typhimurium: effect of ring size. , 1979, Mutation research.

[8]  T. Mashino,et al.  Substituent elimination from p-substituted phenols by cytochrome P450. ipso-Substitution by the oxygen atom of the active species. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[9]  K. Patil,et al.  Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N Ito,et al.  The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. , 1997, Cancer research.

[11]  D. Patel,et al.  Relating repair susceptibility of carcinogen-damaged DNA with structural distortion and thermodynamic stability. , 2002, Nucleic acids research.

[12]  J. Bolton,et al.  Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[13]  E. Gallagher,et al.  Mechanisms of aflatoxin carcinogenesis. , 1994, Annual review of pharmacology and toxicology.

[14]  B. Sopko,et al.  Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy. , 2002, Carcinogenesis.

[15]  J. Bolton,et al.  The influence of 4-alkyl substituents on the formation and reactivity of 2-methoxy-quinone methides: evidence that extended pi-conjugation dramatically stabilizes the quinone methide formed from eugenol. , 1995, Chemico-biological interactions.

[16]  J. Buisson,et al.  Genetic toxicology studies with 2-nitrobenzofurans and 2-nitronaphthofurans. , 1982, Mutation research.

[17]  J. Devillers.  Prediction of mammalian toxicity of organophosphorus pesticides from QSTR modeling , 2004, SAR and QSAR in environmental research.

[18]  D Hoffmann,et al.  The Less Harmful Cigarette: a Controversial Issue. a Tribute to Ernst L. Wynder , 2000 .

[19]  T. Monks,et al.  The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. , 2002, Current drug metabolism.

[20]  R. L. Carter,et al.  IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[21]  J. Vervoort,et al.  The effect of varying halogen substituent patterns on the cytochrome P450 catalysed dehalogenation of 4-halogenated anilines to 4-aminophenol metabolites. , 1995, Biochemical pharmacology.

[22]  J. Miller,et al.  Guanyl O6-arylamination and O6-arylation of DNA by the carcinogen N-hydroxy-1-naphthylamine. , 1978, Cancer research.

[23]  D. Thompson,et al.  Quinone methide formation from para isomers of methylphenol (cresol), ethylphenol, and isopropylphenol: relationship to toxicity. , 1995, Chemical research in toxicology.

[24]  K. Raney,et al.  Alteration of the aflatoxin cyclopentenone ring to a delta-lactone reduces intercalation with DNA and decreases formation of guanine N7 adducts by aflatoxin epoxides. , 1990, Chemical research in toxicology.

[25]  A. Burlingame,et al.  Detection of (3'-hydroxy)-3,N4-benzetheno-2'-deoxycytidine-3'-phosphate by 32P-postlabeling of DNA reacted with p-benzoquinone. , 1990, Carcinogenesis.

[26]  G P Ford,et al.  Relative stabilities of nitrenium ions derived from polycyclic aromatic amines. Relationship to mutagenicity. , 1992, Chemico-biological interactions.

[27]  M. Argus,et al.  Chemical Induction of Cancer: Structural Bases and Biological Mechanisms , 2013 .

[28]  J. Casado,et al.  Stereochemical effects in the metabolic activation of nitrosopiperidines: correlations with genotoxicity. , 2004, Mutation research.

[29]  J. Lewtas,et al.  Formation of DNA adducts in rat lung following chronic inhalation of diesel emissions, carbon black and titanium dioxide particles. , 1994, Carcinogenesis.

[30]  T. Mashino,et al.  Novel metabolic pathway of arylethers by cytochrome P450: cleavage of the oxygen-aromatic ring bond accompanying ipso-substitution by the oxygen atom of the active species in cytochrome P450 models and cytochrome P450. , 1994, Archives of biochemistry and biophysics.

[31]  T. Shimada,et al.  Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. , 1991, Chemical research in toxicology.

[32]  J. Liehr,et al.  Free radical generation by redox cycling of estrogens. , 1990, Free radical biology & medicine.

[33]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[34]  S. Amin,et al.  Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene. , 1994, Cancer research.

[35]  R. Talcott,et al.  Effect of N-Alkyl chain length on the mutagenicity of N-nitrosated 1-naphthyl N-alkylcarbamates. , 1980, Environmental mutagenesis.

[36]  T. Sugimura,et al.  Effect of methyl substitution on mutagenicity of 2-amino-dipyrido [1,2- a :3′,2′- d ] imidazole, Glu-P-2 , 1980 .

[37]  L A Peterson,et al.  Identification of cis-2-butene-1,4-dial as a microsomal metabolite of furan. , 1995, Chemical research in toxicology.

[38]  K. Kaiser,et al.  QSAR in Environmental Toxicology - II , 1984 .

[39]  J. Liehr,et al.  Estrogens as endogenous genotoxic agents--DNA adducts and mutations. , 2000, Journal of the National Cancer Institute. Monographs.

[40]  G. Kampf,et al.  Genotoxic activity of important nitrobenzenes and nitroanilines in the Ames test and their structure-activity relationship. , 1997, Mutation research.

[41]  Ivonne M C M Rietjens,et al.  Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. , 2005, Mutation research.

[42]  A. Basu,et al.  Mutagenicity of nitroaromatic compounds. , 2000, Chemical research in toxicology.

[43]  Sabcho D Dimitrov,et al.  A systematic approach to simulating metabolism in computational toxicology. I. The TIMES heuristic modelling framework. , 2004, Current pharmaceutical design.

[44]  A. Luch,et al.  Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites. , 1999, Carcinogenesis.

[45]  F. Guengerich,et al.  Cytochrome P450 activation of arylamines and heterocyclic amines. , 2005, Annual review of pharmacology and toxicology.

[47]  F. Guengerich.  Metabolism of chemical carcinogens. , 2000, Carcinogenesis.

[48]  R. Harvey,et al.  Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity , 1992 .

[49]  D. Parkin,et al.  Patterns of Cancer in Five Continents , 1990, British Journal of Cancer.

[50]  J. Alexander,et al.  N-acetyltransferase-dependent activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine: formation of 2-amino-1-methyl-6-(5-hydroxy)phenylimidazo [4,5-b]pyridine, a possible biomarker for the reactive dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 2000, Carcinogenesis.

[51]  R. Turesky.  HETEROCYCLIC AROMATIC AMINE METABOLISM, DNA ADDUCT FORMATION, MUTAGENESIS, AND CARCINOGENESIS , 2002, Drug metabolism reviews.

[52]  T. Haack,et al.  From mutagenic to non-mutagenic nitroarenes: effect of bulky alkyl substituents on the mutagenic activity of 4-nitrobiphenyl in Salmonella typhimurium. Part I. Substituents ortho to the nitro group and in 2'-position. , 2000, Mutation research.

[53]  E. Banoglu.  Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. , 2000, Current drug metabolism.

[54]  D. Jerina,et al.  Covalent bonding of bay-region diol epoxides to nucleic acids. , 1991, Advances in experimental medicine and biology.

[55]  A. Grosovsky,et al.  Multimedia Analysis of PAHs and Nitro‐PAH Daughter Products in the Los Angeles Basin , 2001, Risk analysis : an official publication of the Society for Risk Analysis.

[56]  J. Vervoort,et al.  Different metabolic pathways of 2,5-difluoronitrobenzene and 2,5-difluoroaminobenzene compared to molecular orbital substrate characteristics. , 1995, Chemico-biological interactions.

[57]  F. Gonzalez,et al.  DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment. , 1991, Mutation research.

[58]  D. Mills,et al.  A quantitative structure–activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors , 2007, SAR and QSAR in environmental research.

[59]  D. Schrenk,et al.  Denitrosation of N-nitrosomorpholine by liver microsomes; possible role of cytochrome P-450. , 1980, Cancer letters.

[60]  K. Shadan,et al.  Available online: , 2012 .

[61]  R. Marcos,et al.  Comparative genotoxic evaluation of 2-furylethylenes and 5-nitrofurans by using the comet assay in TK6 cells. , 2005, Mutagenesis.

[62]  W. Fritz,et al.  WHO‐IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Voi. 29: Some Industrial Chemicals and Dyestuffs. 416 Seiten. International Agency for Research on Cancer, Lyon 1982. Preis: 60,‐ sfrs; 30,– US$ , 1983 .

[63]  L. Erdinger,et al.  Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part I. Alkylation ortho to the amino function. , 2001, Mutation research.

[64]  M. Manjanatha,et al.  Relationships of DNA adduct formation, K-ras activating mutations and tumorigenic activities of 6-nitrochrysene and its metabolites in the lungs of CD-1 mice. , 1994, Carcinogenesis.

[65]  A. Conney,et al.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. , 1982, Cancer research.

[66]  S. Ishikawa,et al.  Mutagenicity and cross-linking activity of chloroalkylnitrosamines, possible new antitumor lead compounds. , 2003, Mutagenesis.

[67]  S. Kharb.  Toxicology , 1936 .

[68]  R. Chhabra.  NTP technical report on the toxicity studies of benzophenone (CAS No. 119-61-9). Administered in feed to F344/N rats and B6C3F mice. , 2000, Toxicity report series.

[69]  S. Amin,et al.  Comparative metabolism of chrysene and 5-methylchrysene by rat and rainbow trout liver microsomes. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[70]  D. Jerina,et al.  Tumorigenicity of racemic and optically pure bay region diol epoxides and other derivatives of the nitrogen heterocycle dibenz[a,h]acridine on mouse skin. , 2001, Carcinogenesis.

[71]  L. Erdinger,et al.  From mutagenic to non-mutagenic nitroarenes: effect of bulky alkyl substituents on the mutagenic activity of nitroaromatics in Salmonella typhimurium. Part II. Substituents far away from the nitro group. , 2000, Mutation research.

[72]  B. Hingerty,et al.  Effect of ring size on conformations of aromatic amine-DNA adducts: the aniline-C8 guanine adduct resides in the B-DNA major groove. , 1998, Chemical research in toxicology.

[73]  Gabriela L. Borosky.  Theoretical Study Related to the Carcinogenic Activity of Polycyclic Aromatic Hydrocarbon Derivatives , 1999 .

[74]  S. Hecht,et al.  Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. , 1990, Carcinogenesis.

[75]  Y. Zhu,et al.  Reactive intermediates. Some chemistry of quinone methides , 2000 .

[76]  C. Schlatter,et al.  Kinetics of PCB elimination in man , 1988 .

[77]  F. Kadlubar,et al.  A comparison of the carcinogen-DNA adducts formed in rat liver in vivo after administration of single or multiple doses of N-methyl-4-aminoazobenzene. , 1981, Chemico-biological interactions.

[78]  A. Roche,et al.  Organic Chemistry: , 1982, Nature.

[79]  A. Hakura,et al.  Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives. , 2000, Mutation research.

[80]  D. Jerina,et al.  Benzo[c]phenanthrene 3,4-dihydrodiol 1,2-epoxide adducts in native and denatured DNA. , 1996, Carcinogenesis.

[81]  G. Morozzi,et al.  Synthesis and structure--mutagenicity relationship of benzo-annulated cyclopentaphenanthrenes. , 2001, Bioorganic & medicinal chemistry.

[82]  S. Hecht,et al.  Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. , 2005, Chemical research in toxicology.

[83]  M. J. Coon,et al.  Ipso-substitution by cytochrome P450 with conversion of p-hydroxybenzene derivatives to hydroquinone: evidence for hydroperoxo-iron as the active oxygen species. , 2002, Archives of biochemistry and biophysics.

[84]  A. Kohara,et al.  Substituent effect of a fluorine atom on the mutagenicity of nitroquinolines. , 1999, Mutation research.

[85]  R. Minchin,et al.  N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. , 1992, Biochemical and biophysical research communications.

[86]  T. Sugimura,et al.  Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish , 2004, Cancer science.

[87]  J. Epler,et al.  Mutagenicity of 4,4′-MethyIenedianiline Derivatives in the Salmonella histidine reversion assay , 1982, Archives of Toxicology.

[88]  Kurt L. Loening,et al.  Polynuclear aromatic hydrocarbons : measurements, means, and metabolism , 1990 .

[89]  Paola Gramatica,et al.  Quantitative structure-activity relationship modeling of polycyclic aromatic hydrocarbon mutagenicity by classification methods based on holistic theoretical molecular descriptors. , 2007, Ecotoxicology and environmental safety.

[90]  F. Berthou,et al.  Effect of the length of alkyl chain on the cytochrome P450 dependent metabolism of N-diakylnitrosamines. , 1996, Cancer letters.

[91]  T. Sugimura,et al.  Overview of carcinogenic heterocyclic amines. , 1997, Mutation research.

[92]  S. Rokita,et al.  Quinone Methide Alkylation of Deoxycytidine. , 1997, The Journal of organic chemistry.

[93]  G. Eisenbrand,et al.  Fluoro-substituted N-nitrosamines. 8. N-Nitrosodibutylamine and omega-fluorinated analogues: in vivo metabolism in relation to the induction of urinary bladder cancer in the rat. , 1985, Carcinogenesis.

[94]  Stephen S. Hecht,et al.  Approaches to Cancer Prevention Based on an Understanding of N-Nitrosamine Carcinogenesis , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[95]  G. Oakley,et al.  Analysis of polychlorinated biphenyl-DNA adducts by 32P-postlabeling. , 1996, Carcinogenesis.

[96]  G. Habermehl,et al.  ReviewPure appl. Chem: Rinehart, K. L., et al. Marine natural products as sources of antiviral, antimicrobial, and antineoplastic Agents. 53, 795 (1981). (K. L. Rinehart, University of Illinois, Urbana, IL 61801, U.S.A.) , 1983 .

[97]  F. Kadlubar,et al.  Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). , 1995, Cancer research.

[98]  Stephen S Hecht,et al.  Preferential metabolic activation of N-nitrosopiperidine as compared to its structural homologue N-nitrosopyrrolidine by rat nasal mucosal microsomes. , 2003, Chemical research in toxicology.

[99]  E. Boyland.  Chemical carcinogens , 1977, Nature.

[100]  T. Buterin,et al.  Unrepaired fjord region polycyclic aromatic hydrocarbon-DNA adducts in ras codon 61 mutational hot spots. , 2000, Cancer research.

[101]  H. L. Carrell,et al.  Bay-region distortions in a methanol adduct of a bay-region diol epoxide of the carcinogen 5-methylchrysene. , 1996, Carcinogenesis.

[102]  B. Ames,et al.  An improved bacterial test system for the detection and classification of mutagens and carcinogens. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[103]  J. Bolton,et al.  LIFETIME AND REACTIVITY OF AN ULTIMATE TAMOXIFEN CARCINOGEN : THE TAMOXIFEN CARBOCATION , 1998 .

[104]  G. H. Bush,et al.  Pharmacogenetics , 1968 .

[105]  H. L. Carrell,et al.  Three-dimensional structure of anti-5,6-dimethylchrysene-1, 2-dihydrodiol-3,4-epoxide: a diol epoxide with a bay region methyl group. , 1999, Carcinogenesis.

[106]  P. Fu,et al.  Nitro group orientation, reduction potential, and direct‐acting mutagenicity of nitro‐polycyclic aromatic hydrocarbons , 1991, Environmental and molecular mutagenesis.

[107]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[108]  J. Westra,et al.  Partial persistency of 2-aminofluorene and N-acetyl-2-aminofluorene in rat liver DNA. , 1981, Carcinogenesis.

[109]  Ernesto Callegari,et al.  A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.

[110]  W. Gardner,et al.  Carcinogenesis , 1961, The Yale Journal of Biology and Medicine.

[111]  T. Penning,et al.  Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. , 1996, Chemical research in toxicology.

[112]  F. Beland,et al.  Effect of substitution site upon the oxidation potentials of alkylanilines, the mutagenicities of N-hydroxyalkylanilines, and the conformations of alkylaniline-DNA adducts. , 1997, Chemical research in toxicology.

[113]  T. Sugimura,et al.  Effect of methyl substitution on mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline, isolated from broiled sardine. , 1981, Carcinogenesis.

[114]  S. Venitt,et al.  Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. , 1992, Carcinogenesis.

[115]  S. Chen,et al.  Review of the Salmonella typhimurium mutagenicity of benzidine, benzidine analogues, and benzidine-based dyes. , 2006, Mutation research.

[116]  J. Bolton,et al.  Alkylation of 2'-deoxynucleosides and DNA by quinone methides derived from 2,6-di-tert-butyl-4-methylphenol. , 1996, Chemical research in toxicology.

[117]  J. Lay,et al.  Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. , 1992, Chemical research in toxicology.

[118]  Emilio Benfenati,et al.  The Expanding Role of Predictive Toxicology: An Update on the (Q)SAR Models for Mutagens and Carcinogens , 2007, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[119]  B. Hang,et al.  Structural insights by molecular dynamics simulations into specificity of the major human AP endonuclease toward the benzene-derived DNA adduct, pBQ-C. , 2004, Nucleic acids research.

[120]  S. Hecht,et al.  Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.

[121]  George Eadon,et al.  Detection and characterization of DNA adducts formed from metabolites of the fungicide ortho-phenylphenol. , 2002, Journal of agricultural and food chemistry.

[122]  P. van Bladeren,et al.  Structure-activity study on the quinone/quinone methide chemistry of flavonoids. , 2001, Chemical research in toxicology.

[123]  B. Shane,et al.  Basic Environmental Toxicology , 1993 .

[124]  J. Buisson,et al.  Genotoxic activities of 2-nitronaphthofurans and related molecules. , 1986, Mutagenesis.

[125]  H. Glatt,et al.  Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human acetyltransferases and sulfotransferase. , 2002, Carcinogenesis.

[126]  P. Dedon,et al.  Reaction of cis- and trans-2-Butene-1,4-dial with 2'-deoxycytidine to form stable oxadiazabicyclooctaimine adducts. , 2001, Journal of the American Chemical Society.

[127]  J. Rabinowitz,et al.  Quantum mechanical studies of the structure and reactivities of the diol epoxides of benzo[c]phenanthrene. , 1995, Chemical research in toxicology.

[128]  A. Atkinson,et al.  In vitro conversion of environmental estrogenic chemical bisphenol A to DNA binding metabolite(s). , 1995, Biochemical and biophysical research communications.

[129]  K. Saeki,et al.  Potent mutagenic potential of 4-methylquinoline: metabolic and mechanistic considerations. , 1996, Biological and Pharmaceutical Bulletin.

[130]  S. Hecht,et al.  Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3. , 2003, Carcinogenesis.

[131]  F. Beland,et al.  Arylamine-DNA adduct conformation in relation to mutagenesis. , 1997, Mutation research.

[132]  Lothar Erdinger,et al.  Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part II: alkylation far away from the amino function. , 2002, Mutation research.

[133]  D. E. Levin,et al.  Structural features of nitroaromatics that determine mutagenic activity in Salmonella typhimurium. , 1984, Environmental mutagenesis.

[134]  S. Stellman,et al.  Doses of nicotine and lung carcinogens delivered to cigarette smokers. , 2000, Journal of the National Cancer Institute.

[135]  F. Berthou,et al.  Cytochrome P450 hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by human liver microsomes. , 1997, Mutation research.

[136]  D. R. McCalla.  Mutagenicity of nitrofuran derivatives: review. , 1983, Environmental mutagenesis.

[137]  S. Amin,et al.  Mutagenicity of benzo[b]phenanthro[2,3-d]thiophene (BPT) and its metabolites in TA100 and base-specific tester strains (TA7001-TA7006) of Salmonella typhimurium: evidence of multiple pathways for the bioactivation of BPT. , 2004, Mutation research.

[138]  E. Cavalieri,et al.  Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[139]  D W Nebert,et al.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. , 1996, Pharmacogenetics.

[140]  H. Glatt,et al.  Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene. , 1994, Carcinogenesis.

[141]  J. F. Brown,et al.  PCB metabolism, persistence, and health effects after occupational exposure: implications for risk assessment. , 1994, Chemosphere.

[142]  H. Glatt,et al.  Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells. , 1991, Cancer research.

[143]  W. Lijinsky.  Structure-activity relations in carcinogenesis by N-nitroso compounds , 2004, Cancer and Metastasis Reviews.

[144]  W. Bodell,et al.  Detection of 3'-hydroxy-1,N6-benzetheno-2'-deoxyadenosine 3'-phosphate by 32P postlabeling of DNA reacted with p-benzoquinone. , 1991, Chemical research in toxicology.

[145]  W. Bodell,et al.  The benzene metabolite p-benzoquinone forms adducts with DNA bases that are excised by a repair activity from human cells that differs from an ethenoadenine glycosylase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[146]  E. Cavalieri,et al.  Identification and quantification of stable DNA adducts formed from dibenzo[a,l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland. , 2005, Chemical Research in Toxicology.

[147]  T. E. Gram.  Chemically reactive intermediates and pulmonary xenobiotic toxicity. , 1997, Pharmacological reviews.

[148]  D. Warshawsky,et al.  Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. , 2005, Toxicology and applied pharmacology.

[149]  A. Dirr,et al.  Mutagenic nitrenes/nitrenium ions from azido-imidazoarenes and their structure-activity relationships. , 1989, Mutagenesis.

[150]  S. J. Culp,et al.  The effect of deuterium and fluorine substitution upon the mutagenicity of N-hydroxy-2,6-dimethylaniline. , 2002, Mutation research.

[151]  J. Dearden,et al.  Structural basis for the haemotoxicity of dapsone: the importance of the sulphonyl group. , 1997, Toxicology.

[152]  M A Butler,et al.  O(6)-methylguanine DNA adducts associated with occupational nitrosamine exposure. , 2000, Carcinogenesis.

[153]  L. Peterson,et al.  Characterization of nucleoside adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. , 2002, Chemical research in toxicology.

[154]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[155]  U. Hellmann-Blumberg,et al.  Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene , 2000, Breast Cancer Research and Treatment.

[156]  Ericka Stricklin-Parker,et al.  Ann , 2005 .

[157]  S A Kulkarni,et al.  In silico techniques for the study and prediction of xenobiotic metabolism: A review , 2005, Xenobiotica; the fate of foreign compounds in biological systems.

[158]  F. Berthou,et al.  Hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by rat liver microsomes. , 1996, Cancer letters.

[159]  A. Kohara,et al.  Effect of 10-aza-substitution on benzo[a]pyrene mutagenicity in vivo and in vitro. , 2002, Mutation research.

[160]  A. Kohara,et al.  In vivo mutagenicity of benzo[f]quinoline, benzo[h]quinoline, and 1,7-phenanthroline using the lacZ transgenic mice. , 2004, Mutation research.

[161]  G. Pacifici,et al.  Advances in Drug Metabolism in Man , 1995 .

[162]  Yin-Tak Woo,et al.  Natural, metal, fiber, and macromolecular carcinogens , 1988 .

[163]  H S Rosenkranz,et al.  Structural requirements for the mutagenicity of environmental nitroarenes. , 1984, Mutation research.

[164]  E. Snyderwine,et al.  DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. , 1999, Carcinogenesis.

[165]  J. W. Flesher,et al.  7-Sulfooxymethyl-12-methylbenz[a]anthracene is an exceptionally reactive electrophilic mutagen and ultimate carcinogen. , 1997, Biochemical and biophysical research communications.

[166]  D. Jerina,et al.  Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells. , 1983, Cancer research.

[167]  A. Hakura,et al.  Effects of oligofluorine substitution on the mutagenicity of quinoline: a study with twelve fluoroquinoline derivatives. , 1999, Mutation research.

[168]  P N Judson,et al.  Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.

[169]  W. A. Lopes,et al.  Electrochemical reduction potentials of 1-nitropyrene, 9-nitroanthracene, 6-nitrochrysene and 3-nitrofluoranthene and their correlation with direct-acting mutagenicities , 2005 .

[170]  A. Natarajan.  Mutagenesis , 1998, Cytogenetic and Genome Research.

[171]  D. Brousmiche,et al.  Quinone methide intermediates in organic photochemistry , 2001 .

[172]  R. Sinha,et al.  High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. , 1995, Cancer research.

[173]  W. Bodell,et al.  Formation of DNA adducts by microsomal and peroxidase activation of p-cresol: role of quinone methide in DNA adduct formation. , 2001, Chemico-biological interactions.

[174]  A. Luch,et al.  Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti (11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. , 1995, Carcinogenesis.

[175]  E. Hopmans,et al.  Health risks of heterocyclic amines. , 1997, Mutation research.

[176]  P. Hollenberg,et al.  Metabolism of the β-oxidized intermediates of N-nitrosodi-n-propylamine: N-nitroso-β-hydroxypropylpropylamine and N-nitroso-β-oxopropylpropylamine , 2001 .

[177]  H. Kuramochi.  Conformational studies and electronic structures of tamoxifen and toremifene and their allylic carbocations proposed as reactive intermediates leading to DNA adduct formation. , 1996, Journal of medicinal chemistry.

[178]  L A Peterson,et al.  A reactive metabolite of furan, cis-2-butene-1,4-dial, is mutagenic in the Ames assay. , 2000, Chemical research in toxicology.

[179]  R. Pahlman.  Mutagenicity of naphthacene, a non-bay-region aromatic hydrocarbon, in Salmonella. , 1988, Mutation research.

[180]  R. Harvey.  Polycyclic hydrocarbons and carcinogenesis , 1985 .

[181]  J. Bolton,et al.  The influence of the p-alkyl substituent on the isomerization of o-quinones to p-quinone methides: potential bioactivation mechanism for catechols. , 1995, Chemical research in toxicology.

[182]  R Montesano,et al.  Antibodies against 7-methyldeoxyguanosine: its detection in rat peripheral blood lymphocyte DNA and potential applications to molecular epidemiology. , 1988, Cancer research.

[183]  Jian Yan,et al.  Photomutagenicity of 16 polycyclic aromatic hydrocarbons from the US EPA priority pollutant list. , 2004, Mutation research.

[184]  Iarc Monographs,et al.  Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. , 2002, IARC monographs on the evaluation of carcinogenic risks to humans.

[185]  E. LaVoie,et al.  Effects of ortho-methyl substituents on the mutagenicity of aminobiphenyls and aminonaphthalenes. , 1981, Mutation research.

[186]  J Ashby,et al.  Evaluation of two suggested methods of deactivating organic carcinogens by molecular modification. , 1982, Carcinogenesis.

[187]  Y. S. Wu,et al.  Metabolism of isomeric nitrobenzo[a]pyrenes leading to DNA adducts and mutagenesis. , 1997, Mutation research.

[188]  Reactions of dihydrodiol epoxides of 5-methylchrysene and 5, 6-dimethylchrysene with DNA and deoxyribonucleotides. , 1999, Chemical research in toxicology.

[189]  T. Chakrabarti,et al.  Quantitative Structure-Activity Relationships Based on Functional and Structural Characteristics of Organic Compounds , 2001, SAR and QSAR in environmental research.

[190]  J. Bolton,et al.  Role of quinones in toxicology. , 2000, Chemical research in toxicology.

[191]  S. Meegalla,et al.  Bioassay of quinoline, 5-fluoroquinoline, carbazole, 9-methylcarbazole and 9-ethylcarbazole in newborn mice. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[192]  G. Klopman.  MULTICASE 1. A Hierarchical Computer Automated Structure Evaluation Program , 1992 .

[193]  S. Amin,et al.  Tumor-initiating activity on mouse skin of bay region diol-epoxides of 5,6-dimethylchrysene and benzo[c]phenanthrene. , 1993, Carcinogenesis.

[194]  Structure-activity relationships within various series of p-phenylenediamine derivatives. , 1994, Mutation research.

[195]  F. Beland,et al.  Formation of DNA adducts in vitro and in Salmonella typhimurium upon metabolic reduction of the environmental mutagen 1-nitropyrene. , 1983, Cancer research.

[196]  D. Rickert.  Toxicity of nitroaromatic compounds. , 1985 .

[197]  S. Hecht,et al.  Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA. , 2004, Chemical research in toxicology.

[198]  S. Asakura,et al.  In vivo genotoxicity and DNA adduct levels in the liver of rats treated with safrole. , 1998, Carcinogenesis.

[199]  A. Kohara,et al.  Nitrogen-substitution effect on in vivo mutagenicity of chrysene. , 2005, Mutation research.

[200]  H. L. Carrell,et al.  Dibenzo[a,l]pyrene (dibenzo[def,p]chrysene): fjord-region distortions. , 1998, Carcinogenesis.

[201]  H. Glatt,et al.  Mutagenicity of K-region oxides and imines of chrysene, benzo[c]phenanthrene and benzo[g]chrysene in Salmonella typhimurium. , 1994, Mutation research.

[202]  G. Williams,et al.  Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. , 1993, Cancer research.

[203]  G. Morozzi,et al.  Synthesis and mutagenicity of some cyclopenta[c]phenanthrenes and indeno[c]phenanthrenes. , 1996, Carcinogenesis.

[204]  M L Gargas,et al.  Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. , 1993, Toxicology and applied pharmacology.

[205]  D. Sanderson,et al.  Computer Prediction of Possible Toxic Action from Chemical Structure; The DEREK System , 1991, Human & experimental toxicology.

[206]  L. Robertson,et al.  Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. , 1990, Critical reviews in toxicology.

[207]  F. Guengerich,et al.  Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. , 1998, Chemical research in toxicology.

[208]  M. Murkovic.  Formation of heterocyclic aromatic amines in model systems. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[209]  M. Shahin.  Relationships between structure and mutagenic activity of environmental chemicals. , 1987, Mutation research.

[210]  M. Rogawski,et al.  Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. , 1990, Pharmacological reviews.

[211]  G. Margison,et al.  Methylated purines in the deoxyribonucleic acid of various Syrian-golden-hamster tissues after administration of a hepatocarcinogenic dose of dimethylnitrosamine. , 1976, The Biochemical journal.

[212]  A. Dipple,et al.  Metabolic activation of benzo[g]chrysene in the human mammary carcinoma cell line MCF-7. , 1997, Cancer research.

[213]  R. Peto,et al.  Chronic nitrosamine ingestion in 1040 rodents: the effect of the choice of nitrosamine, the species studied, and the age of starting exposure. , 1991, Cancer research.

[214]  D. Li,et al.  Evidence for the DNA binding and adduct formation of estrone and 17beta-estradiol after dimethyldioxirane activation. , 1998, Chemico-biological interactions.

[215]  L. J. Chen,et al.  Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. , 1997, Chemical research in toxicology.

[216]  E. Estrada.  Structure-mutagenicity relationships in 2-furylethylene derivatives. A molecular orbital study of the role of nitro groups. , 1998, Mutation research.

[217]  T. I. Apak,et al.  Mechanism of lower genotoxicity of toremifene compared with tamoxifen. , 2001, Cancer research.

[218]  Gilles Klopman,et al.  META, 3. A Genetic Algorithm for Metabolic Transform Priorities Optimization , 1997, J. Chem. Inf. Comput. Sci..

[219]  E. Cavalieri,et al.  Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism , 2002, Cellular and Molecular Life Sciences CMLS.

[220]  S. Amin,et al.  Methylchrysenes as Probes for the Mechanism of Metabolic Activation of Carcinogenic Methylated Polynuclear Aromatic Hydrocarbons , 1986 .

[221]  S. Amin,et al.  Characterization of DNA adducts formed by the four configurationally isomeric 5,6-dimethylchrysene 1,2-dihydrodiol 3,4-epoxides. , 1997, Chemical research in toxicology.

[222]  L. Pannell,et al.  Chemical characterization of DNA adducts derived from the configurationnally isomeric benzo[c]phenanthrene-3,4-diol 1,2-epoxides , 1987 .